Microarray Market Report 2026

Microarray Market Overview

• Microarray market size has reached to $5.62 billion in 2025 • Expected to grow to $9.1 billion in 2030 at a compound annual growth rate (CAGR) of 10.2% • Growth Driver: Microarray Market Set To Grow As Incidence Of Cancer Cases Rises Globally • Market Trend: Product Innovation As Key Players Introduce Advanced Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Microarray Market?

Microarray refers to a common laboratory technique that includes adhering a variety of tens of thousands to millions of recognized nucleic acid fragments to a solid surface known as a chip. It is frequently used for a variety of applications in scientific and medical research, like detecting particular DNA sequences and assessing gene expression. The main types of microarrays are DNA microarray, protein microarray, and others. A DNA microarray refers to a cluster of small DNA spots adhered to a solid substrate, which is used to identify whether a gene mutation, such as those in BRCA1 or BRCA2, is present in the DNA of a certain person. They are used for disease diagnosis, cancer genomic analysis, drug discovery, genomic sequencing, expression analysis, toxicological research, and other applications by the pharmaceutical industry, biotechnology industry, academic and research laboratories, and other end-users.

What Is The Microarray Market Growth Forecast?

The microarray market size is expected to see rapid growth in the next few years. It will grow to $9.1 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, advancements in bioinformatics processing tools, rising integration of automation in microarray workflows, expanding applications in toxicological testing, growing need for high-throughput genomic analysis. Major trends in the forecast period include genomics-driven microarray optimization, cloud-based data processing for microarray analysis, AI-enhanced gene expression interpretation, automated microarray manufacturing systems, iot-enabled sample tracking and monitoring.

Global Microarray Market Segmentation

1) By Type: DNA Microarray, Protein Microarray, Other Types 2) By Application: Disease Diagnosis, Cancer Genomic Analysis, Drug Discovery, Genomic Sequencing, Expression Analysis, Toxicological Research, Other Applications 3) By End-User: Pharmaceutical Industry, Biotechnology Industry, Academic and Research Laboratories, Other End-Users Subsegments: 1) By DNA Microarray: CDNA Microarray, Oligonucleotide Microarray, SNP Microarray, Comparative Genomic Hybridization (CGH) Microarray 2) By Protein Microarray: Antibody Microarray, Antigen Microarray, Receptor Microarray, Enzyme Microarray 3) By Other Types: Cell Microarray, Tissue Microarray, RNA Microarray

What Is The Driver Of The Microarray Market?

The rise in the incidence of cancer cases is expected to drive the growth of the microarray market in the future. Cancer refers to a condition in when a few of the body's cells grow out of control and spread to other bodily regions. The increase in cancer cases is mostly driven by the increasing incidence of established cancer risk factors, exposure to specific chemicals, an aging population, and common cancers such as breast cancer, lung cancer, and bronchial cancer, where microarray allows researchers to identify changes in gene expression that may be associated with cancer. For instance, in January 2023, according to the American Cancer Society, a US-based voluntary health organization, about 9,910 children in the US under the age of 15 were diagnosed with cancer, and approximately 1,040 children under the age of 15 died from cancer in 2023. Therefore, the rise in the incidence of cancer cases is driving the growth of the microarray industry.

Key Players In The Global Microarray Market

Major companies operating in the microarray market are Agilent Technologies Inc., Arrayit Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, GE Healthcare Inc., Illumina Inc., Merck KGaA, Microarray Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., Molecular Devices LLC, RayBiotech Life Inc., Schott Minifab AG, Full Moon Biosystems Inc., CapitalBio Technology Co. Ltd., Roche Diagnostics Ltd., Affymetrix Inc., SCIENION AG, NextGen Sciences Inc., PathogenDx Inc., BioGenomics Limited, BioMicro Systems Inc., Biostatus Limited, Biotechrabbit GmbH, INanoBio Inc.

Global Microarray Market Trends and Insights

Major companies in the microarray market are concentrating their efforts on developing chromosomal microarrays to strengthen their position in the market. Chromosomal Microarray Analysis (CMA) stands at the forefront of transformative technologies in genomic medicine, propelling diagnostic capabilities to unprecedented heights. For instance, in August 2023, Thermo Fisher Scientific, Inc., a US-based supplier of analytical instruments, life sciences solutions, specialty diagnostics, laboratory, pharmaceutical, and biotechnology services, launched the Applied Biosystems CytoScan HD Accel array, a novel chromosomal microarray designed to improve productivity, efficiency, and profitability in cytogenetic research labs. This innovative array boasts an industry-leading two-day turnaround time, providing a significant advancement in the field. The Applied Biosystems CytoScan HD Accel array conducts a comprehensive analysis of the entire human genome. With enhanced coverage spanning over 5,000 critical genomic regions, it provides valuable insights into chromosomal variants. This advanced technology proves beneficial for a wide range of applications, including prenatal and postnatal research, as well as cancer-related studies.

What Are Latest Mergers And Acquisitions In The Microarray Market?

In May 2024, Bruker, a US-based manufacturer of analytical instrumentation and scientific solutions, acquired NanoString Business for an undisclosed amount. The acquisition of NanoString's business by Bruker aims to strengthen Bruker's position in the field of life sciences and enhance its portfolio of analytical tools and solutions. NanoString Business is a US-based biotechnology company that manufactures DNA and protein microarrays and biosensors.

Regional Outlook

North America was the largest region in the microarray market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global microarray market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Microarray Market?

The microarray market consists of revenues earned by entities by providing services such as genotyping and methylation array services, analytical protein microarray, functional protein array, reverse-phase protein array, and peptide microarray. The value of associated goods sold by the service provider or incorporated into the service providing is included in the market value. The microarray market also includes sales of microarray slides or chips and priming, microarray fluorescence and colorimetric scanners, printers, hybridization stations or DNA and RNA assays, whole genome sequencing, cDNA Microarray, BAC microarray, oligo microarray, which are used in providing microarray services. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Microarray Market Report 2026?

The microarray market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the microarray industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.